Linking aberrant splicing to cardiac aging : unravelling SRPK2
The gradual and inevitable process of aging can lead to detrimental effects such as disruptions in cellular processes and accumulation of damage in cells. It has been shown that the number of alternatively spliced genes significantly increases with age, and that aberrant splicing is one of the major...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Final Year Project |
| Language: | English |
| Published: |
2016
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/67927 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Nanyang Technological University |
| Language: | English |
| Summary: | The gradual and inevitable process of aging can lead to detrimental effects such as disruptions in cellular processes and accumulation of damage in cells. It has been shown that the number of alternatively spliced genes significantly increases with age, and that aberrant splicing is one of the major causes of a few age-related diseases such as Hutchinson-Gilford progeria syndrome (HGPS), frontotemporal lobar degeneration (FTLD), or Alzheimer's disease (AD). Identification of the key players in splicing can lead to a better understanding of the relationship between aberrant splicing and cardiac aging. One essential component of the splicing process is SRPK2, a member of the the Serine-Arginine Rich Protein Kinase (SRPK) family. A thorough understanding of SRPK2, its interactors, its regulatory mechanism, and its functions the aim of this project. With methods such as BioID proximity labelling, western blots, immunoprecipitation and real time PCR, a few possible interactors of SRPK2 have been short listed, and the regulatory mechanism of SRPK2 cellular levels have been proposed. |
|---|